Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ghulam J Mufti

Showing results (61-70 of 224) with videos related to

Pageof 23
Sort By:
British Journal of Haematology|February 1, 2006
T-cell lymphoblastic lymphoma presenting as an intra-muscular massZiyi Lim, Sunil Gupta, Jonathan R Salisbury, et al.
Oncogene|April 24, 2002
Increased error-prone non homologous DNA end-joining--a proposed mechanism of chromosomal instability in Bloom's syndromeTerry J Gaymes, Phillip S North, Nicola Brady, et al.
Journal of Biochemical and Biophysical Methods|April 23, 2003
High efficiency protein transduction of quiescent and proliferating primary hematopoietic cellsNicholas C Lea, Andrea G S Buggins, Stephen J Orr, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 24, 2005
Liver transplantation for HCV-related cirrhosis in a patient with gastric mucosa-associated lymphoma (MALToma) pretreated with rituximabMatthew R Foxton, Lisa Knight, Alex S Knisely, et al.
British Journal of Haematology|August 10, 2007
The leukaemia-associated antigen, SSX2IP, is expressed during mitosis on the surface of myeloid leukaemia cellsFrances A K Denniss, Angela Breslin, Wendy Ingram, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 18, 2011
Alemtuzumab-based reduced-intensity conditioning allogeneic transplantation for myeloma and plasma cell leukemia - a single-institution experienceKarthik Ramasamy, Shameem Mahmood, Ziyi Lim, et al.
British Journal of Haematology|March 30, 2010
Rapid recovery of lymphocyte subsets is not associated with protection from relapse of myelodysplastic syndromes and acute myeloid leukaemia after haematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumabKatie Matthews, ZiYi Lim, Laurence Pearce, et al.
Blood|April 3, 2004
Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulphan, and alemtuzumab (FBC) conditioningAloysius Y L Ho, Antonio Pagliuca, Michelle Kenyon, et al.
British Journal of Haematology|May 13, 2015
Chronic relapsing remitting Sweet syndrome--a harbinger of myelodysplastic syndromeAustin G Kulasekararaj, Shahram Kordasti, Tanya Basu, et al.
British Journal of Haematology|July 19, 2006
High incidence of therapy-related myelodysplasia and acute leukaemia in general haematology clinic patients treated with fludarabine and cyclophosphamide for indolent lymphoproliferative disordersStella J Bowcock, Saad M B Rassam, Ziyi Lim, et al.
Pageof 23

Showing results (61-70 of 224) with videos related to

Sort By:
Pageof 23
British Journal of Haematology|February 1, 2006
T-cell lymphoblastic lymphoma presenting as an intra-muscular massZiyi Lim, Sunil Gupta, Jonathan R Salisbury, et al.
Oncogene|April 24, 2002
Increased error-prone non homologous DNA end-joining--a proposed mechanism of chromosomal instability in Bloom's syndromeTerry J Gaymes, Phillip S North, Nicola Brady, et al.
Journal of Biochemical and Biophysical Methods|April 23, 2003
High efficiency protein transduction of quiescent and proliferating primary hematopoietic cellsNicholas C Lea, Andrea G S Buggins, Stephen J Orr, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 24, 2005
Liver transplantation for HCV-related cirrhosis in a patient with gastric mucosa-associated lymphoma (MALToma) pretreated with rituximabMatthew R Foxton, Lisa Knight, Alex S Knisely, et al.
British Journal of Haematology|August 10, 2007
The leukaemia-associated antigen, SSX2IP, is expressed during mitosis on the surface of myeloid leukaemia cellsFrances A K Denniss, Angela Breslin, Wendy Ingram, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 18, 2011
Alemtuzumab-based reduced-intensity conditioning allogeneic transplantation for myeloma and plasma cell leukemia - a single-institution experienceKarthik Ramasamy, Shameem Mahmood, Ziyi Lim, et al.
British Journal of Haematology|March 30, 2010
Rapid recovery of lymphocyte subsets is not associated with protection from relapse of myelodysplastic syndromes and acute myeloid leukaemia after haematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumabKatie Matthews, ZiYi Lim, Laurence Pearce, et al.
Blood|April 3, 2004
Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulphan, and alemtuzumab (FBC) conditioningAloysius Y L Ho, Antonio Pagliuca, Michelle Kenyon, et al.
British Journal of Haematology|May 13, 2015
Chronic relapsing remitting Sweet syndrome--a harbinger of myelodysplastic syndromeAustin G Kulasekararaj, Shahram Kordasti, Tanya Basu, et al.
British Journal of Haematology|July 19, 2006
High incidence of therapy-related myelodysplasia and acute leukaemia in general haematology clinic patients treated with fludarabine and cyclophosphamide for indolent lymphoproliferative disordersStella J Bowcock, Saad M B Rassam, Ziyi Lim, et al.
Pageof 23